热门资讯> 正文
Centessa Pharmaceuticals定价2.25亿美元股权出售
2024-09-13 12:38
- Centessa Pharmaceuticals (NASDAQ:CNTA) has priced an upsized underwritten public offering of 15.25M ADS, each representing one ordinary share, at $14.75 per ADS for the aggregate gross proceeds of approximately $225 million.
- Closing date is September 16, 2024.
- The underwriters has a 30-day option to purchase up to an additional 2,288,135 ADSs at the public offering price.
- Source: Press Release
More on Centessa Pharmaceuticals
- Seeking Alpha’s Quant Rating on Centessa Pharmaceuticals
- Historical earnings data for Centessa Pharmaceuticals
- Financial information for Centessa Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
